Name | Number of supported studies | Average coverage | |
---|---|---|---|
CD8-positive, alpha-beta T cell | 38 studies | 53% ± 17% | |
T cell | 18 studies | 33% ± 11% | |
naive thymus-derived CD8-positive, alpha-beta T cell | 14 studies | 74% ± 17% | |
CD8-positive, alpha-beta memory T cell | 12 studies | 60% ± 16% | |
effector memory CD8-positive, alpha-beta T cell | 12 studies | 49% ± 20% | |
mucosal invariant T cell | 10 studies | 23% ± 9% | |
gamma-delta T cell | 8 studies | 28% ± 12% | |
mature NK T cell | 7 studies | 32% ± 8% | |
effector CD8-positive, alpha-beta T cell | 7 studies | 57% ± 17% | |
central memory CD8-positive, alpha-beta T cell | 5 studies | 55% ± 19% | |
exhausted T cell | 5 studies | 63% ± 21% | |
effector memory CD8-positive, alpha-beta T cell, terminally differentiated | 4 studies | 39% ± 14% | |
CD4-positive, alpha-beta T cell | 4 studies | 19% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 173.89 | 570 / 578 | 67% | 2.82 | 779 / 1155 |
stomach | 89% | 117.45 | 321 / 359 | 57% | 2.14 | 164 / 286 |
thymus | 90% | 105.30 | 590 / 653 | 55% | 33.30 | 335 / 605 |
prostate | 92% | 84.80 | 226 / 245 | 45% | 0.89 | 226 / 502 |
uterus | 71% | 59.97 | 120 / 170 | 60% | 4.39 | 276 / 459 |
intestine | 66% | 180.33 | 633 / 966 | 57% | 1.65 | 298 / 527 |
breast | 62% | 52.87 | 284 / 459 | 57% | 2.14 | 637 / 1118 |
skin | 57% | 33.34 | 1030 / 1809 | 58% | 4.49 | 273 / 472 |
kidney | 49% | 39.70 | 44 / 89 | 54% | 3.08 | 488 / 901 |
lymph node | 0% | 0 | 0 / 0 | 100% | 17.92 | 29 / 29 |
spleen | 100% | 751.22 | 241 / 241 | 0% | 0 | 0 / 0 |
bladder | 52% | 89.67 | 11 / 21 | 47% | 2.16 | 235 / 504 |
pancreas | 43% | 18.27 | 142 / 328 | 53% | 1.62 | 95 / 178 |
tonsil | 0% | 0 | 0 / 0 | 87% | 4.17 | 39 / 45 |
esophagus | 56% | 32.19 | 814 / 1445 | 29% | 0.74 | 53 / 183 |
peripheral blood | 82% | 892.16 | 763 / 929 | 0% | 0 | 0 / 0 |
adipose | 80% | 61.59 | 965 / 1204 | 0% | 0 | 0 / 0 |
liver | 52% | 25.85 | 118 / 226 | 22% | 0.87 | 88 / 406 |
ovary | 23% | 11.69 | 41 / 180 | 31% | 1.22 | 133 / 430 |
adrenal gland | 40% | 17.40 | 103 / 258 | 8% | 0.21 | 18 / 230 |
blood vessel | 46% | 32.10 | 615 / 1335 | 0% | 0 | 0 / 0 |
brain | 24% | 17.90 | 633 / 2642 | 5% | 0.12 | 34 / 705 |
heart | 26% | 11.29 | 222 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 15% | 0.75 | 12 / 80 |
muscle | 7% | 2.58 | 56 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006955 | Biological process | immune response |
GO_0002250 | Biological process | adaptive immune response |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0050852 | Biological process | T cell receptor signaling pathway |
GO_0042110 | Biological process | T cell activation |
GO_0009986 | Cellular component | cell surface |
GO_0031901 | Cellular component | early endosome membrane |
GO_0042101 | Cellular component | T cell receptor complex |
GO_0043235 | Cellular component | receptor complex |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0015026 | Molecular function | coreceptor activity |
GO_0042288 | Molecular function | MHC class I protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CD8B |
Protein name | CD8 subunit beta CD8 antigen T-cell surface glycoprotein CD8 beta chain (CD antigen CD8b) |
Synonyms | CD8B1 |
Description | FUNCTION: Integral membrane glycoprotein that plays an essential role in the immune response and serves multiple functions in responses against both external and internal offenses. In T-cells, functions primarily as a coreceptor for MHC class I molecule:peptide complex. The antigens presented by class I peptides are derived from cytosolic proteins while class II derived from extracellular proteins. Interacts simultaneously with the T-cell receptor (TCR) and the MHC class I proteins presented by antigen presenting cells (APCs). In turn, recruits the Src kinase LCK to the vicinity of the TCR-CD3 complex. A palmitoylation site in the cytoplasmic tail of CD8B chain contributes to partitioning of CD8 into the plasma membrane lipid rafts where signaling proteins are enriched. Once LCK recruited, it initiates different intracellular signaling pathways by phosphorylating various substrates ultimately leading to lymphokine production, motility, adhesion and activation of cytotoxic T-lymphocytes (CTLs). Additionally, plays a critical role in thymic selection of CD8+ T-cells. . |
Accessions | ENST00000393761.6 [P10966-9] P10966 ENST00000431506.3 ENST00000393759.6 [P10966-2] E9PD41 ENST00000390655.12 [P10966-1] ENST00000331469.6 [P10966-6] A0N2Q4 ENST00000349455.7 [P10966-3] |